| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.33 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |